Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 298-308

  Hanssen, Lydia ^a   Frye, Björn C ^a   Ostendorf, Tammo ^a   Alidousty, Christina ^a   Djudjaj, Sonja ^a   Boor, Peter ^a,b   Rauen, Thomas ^a   Floege, Jürgen ^a   Mertens, Peter R ^c   Raffetseder, Ute ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Physics and Informatics   (Slovakia)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HYDROGEN PEROXIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; Y BOX BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; MALE; MESANGIUM CELL; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CALCINEURIN; CELL LINE; CELL LINE, TRANSFORMED; CELLS, CULTURED; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; GLOMERULAR MESANGIUM; HEK293 CELLS; HUMANS; MESANGIAL CELLS; MICE; RATS; Y-BOX-BINDING PROTEIN 1;

EID: 79960426827     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100382     Document Type: Article

References (56)

1. Burke, J. F., Jr., J. D. Pirsch, E. L. Ramos, D. R. Salomon, D. M. Stablein, D. H. Van Buren, and J. C. West. 1994. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N. Engl. J. Med. 331: 358-363.
2. Hariharan, S., C. P. Johnson, B. A. Bresnahan, S. E. Taranto, M. J. McIntosh, and D. Stablein. 2000. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 342: 605-612.
3. Tilney, N. L., E. L. Milford, J. L. Araujo, T. B. Strom, C. B. Carpenter, and R. L. Kirkman. 1984. Experience with cyclosporine and steroids in clinical renal transplantation. Ann. Surg. 200: 605-613.
4. Mihatsch, M. J., M. Kyo, K. Morozumi, Y. Yamaguchi, V. Nickeleit, and B. Ryffel. 1998. The side-effects of ciclosporine-A and tacrolimus. Clin. Nephrol. 49: 356-363.
5. Ekberg, H. 2008. Calcineurin inhibitor sparing in renal transplantation. Transplantation 86: 761-767.
6. Ninova, D., M. Covarrubias, D. J. Rea, W. D. Park, J. P. Grande, and M. D. Stegall. 2004. Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin. Transplantation 78: 338-344.
7. Shihab, F. S., T. F. Andoh, A. M. Tanner, and W. M. Bennett. 1997. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am. J. Kidney Dis. 30: 71-81.
8. Ignotz, R. A., and J. Massagué. 1986. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261: 4337-4345.
9. Schnaper, H. W., T. Hayashida, S. C. Hubchak, and A. C. Poncelet. 2003. TGFbeta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal Physiol. 284: F243-F252.
10. Poncelet, A. C., and H. W. Schnaper. 1998. Regulation of human mesangial cell collagen expression by transforming growth factor-beta1. Am. J. Physiol. 275: F458-F466.
11. Islam, M., J. F. Burke, Jr., T. A. McGowan, Y. Zhu, S. R. Dunn, P. McCue, J. Kanalas, and K. Sharma. 2001. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int. 59: 498-506. (Pubitemid 32157915)
12. Hänsch, G. M., C. Wagner, A. Bürger, W. Dong, G. Staehler, and M. Stoeck. 1995. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J. Cell. Physiol. 163: 451-457.
13. Gupta, S., M. R. Clarkson, J. Duggan, and H. R. Brady. 2000. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. 58: 1389-1399.
14. Akool, S., A. Doller, A. Babelova, W. Tsalastra, K. Moreth, L. Schaefer, J. Pfeilschifter, and W. Eberhardt. 2008. Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506. J. Immunol. 181: 2831-2845.
15. Lu, Z. H., J. T. Books, and T. J. Ley. 2005. YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. Mol. Cell. Biol. 25: 4625-4637.
16. Schittek, B., K. Psenner, B. Sauer, F. Meier, T. Iftner, and C. Garbe. 2007. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. Int. J. Cancer 120: 2110-2118. (Pubitemid 46555847)
17. Fraser, D. J., A. O. Phillips, X. Zhang, C. R. van Roeyen, P. Muehlenberg, A. En- Nia, and P. R. Mertens. 2008. Y-box protein-1 controls transforming growth factor-beta1 translation in proximal tubular cells. Kidney Int. 73: 724-732.
18. Raffetseder, U., B. Frye, T. Rauen, K. Jürchott, H. D. Royer, P. L. Jansen, and P. R. Mertens. 2003. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J. Biol. Chem. 278: 18241-18248.
19. Norman, J. T., G. E. Lindahl, K. Shakib, A. En-Nia, E. Yilmaz, and P. R. Mertens. 2001. The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J. Biol. Chem. 276: 29880-29890.
20. Mertens, P. R., S. Harendza, A. S. Pollock, and D. H. Lovett. 1997. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J. Biol. Chem. 272: 22905-22912.
21. Raffetseder, U., T. Rauen, S. Djudjaj, M. Kretzler, A. En-Nia, F. Tacke, H. W. Zimmermann, P. J. Nelson, B. C. Frye, J. Floege, et al. 2009. Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. Kidney Int. 75: 185-196.
22. Krohn, R., U. Raffetseder, I. Bot, A. Zernecke, E. Shagdarsuren, E. A. Liehn, P. J. van Santbrink, P. J. Nelson, E. A. Biessen, P. R. Mertens, and C. Weber. 2007. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice. Circulation 116: 1812-1820. (Pubitemid 350287106)
23. Rauen, T., U. Raffetseder, B. C. Frye, S. Djudjaj, P. J. Mühlenberg, F. Eitner, U. Lendahl, J. Bernhagen, S. Dooley, and P. R. Mertens. 2009. YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation. J. Biol. Chem. 284: 26928-26940.
24. van Roeyen, C. R., F. Eitner, S. Martinkus, S. R. Thieltges, T. Ostendorf, D. Bokemeyer, B. Lüscher, J. M. Lüscher-Firzlaff, J. Floege, and P. R. Mertens. 2005. Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease. J. Am. Soc. Nephrol. 16: 2985-2996.
25. Feng, Q., S. Huang, A. Zhang, Q. Chen, X. Guo, R. Chen, and T. Yang. 2009. Ybox protein 1 stimulates mesangial cell proliferation via activation of ERK1/2. Nephron, Exp. Nephrol. 113: e16-e25.
26. Zhang, A., X. Liu, J. G. Cogan, M. D. Fuerst, J. A. Polikandriotis, R. J. Kelm, Jr., and A. R. Strauch. 2005. YB-1 coordinates vascular smooth muscle alpha-actin gene activation by transforming growth factor beta1 and thrombin during differentiation of human pulmonary myofibroblasts. Mol. Biol. Cell 16: 4931-4940.
27. Higashi, K., Y. Inagaki, K. Fujimori, A. Nakao, H. Kaneko, and I. Nakatsuka. 2003. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem. 278: 43470-43479.
28. Higashi, K., Y. Inagaki, N. Suzuki, S. Mitsui, A. Mauviel, H. Kaneko, and I. Nakatsuka. 2003. Y-box-binding protein YB-1 mediates transcriptional repression of human alpha 2(I) collagen gene expression by interferon-gamma. J. Biol. Chem. 278: 5156-5162.
29. Sun, W., F. Hou, M. P. Panchenko, and B. D. Smith. 2001. A member of the Ybox protein family interacts with an upstream element in the alpha1(I) collagen gene. Matrix Biol. 20: 527-541.
30. Mundel, P., J. Reiser, A. Zúñiga Mejía Borja, H. Pavenstädt, G. R. Davidson, W. Kriz, and R. Zeller. 1997. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236: 248-258.
31. Sawada, S., G. Suzuki, Y. Kawase, and F. Takaku. 1987. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J. Immunol. 139: 1797-1803.
32. Sorokin, A. V., A. A. Selyutina, M. A. Skabkin, S. G. Guryanov, I. V. Nazimov, C. Richard, J. Th'ng, J. Yau, P. H. Sorensen, L. P. Ovchinnikov, and V. Evdokimova. 2005. Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response. EMBO J. 24: 3602-3612.
33. Krauskopf, A., T. M. Buetler, N. S. Nguyen, K. Macé, and U. T. Ruegg. 2002. Cyclosporin A-induced free radical generation is not mediated by cytochrome P-450. Br. J. Pharmacol. 135: 977-986.
34. Coles, L. S., L. Lambrusco, J. Burrows, J. Hunter, P. Diamond, A. G. Bert, M. A. Vadas, and G. J. Goodall. 2005. Phosphorylation of cold shock domain/Ybox proteins by ERK2 and GSK3beta and repression of the human VEGF promoter. FEBS Lett. 579: 5372-5378.
35. Stratford, A. L., C. J. Fry, C. Desilets, A. H. Davies, Y. Y. Cho, Y. Li, Z. Dong, I. M. Berquin, P. P. Roux, and S. E. Dunn. 2008. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells. Breast Cancer Res. 10: R99.
36. Evdokimova, V., P. Ruzanov, M. S. Anglesio, A. V. Sorokin, L. P. Ovchinnikov, J. Buckley, T. J. Triche, N. Sonenberg, and P. H. Sorensen. 2006. Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol. Cell. Biol. 26: 277-292.
37. Sutherland, B. W., J. Kucab, J. Wu, C. Lee, M. C. Cheang, E. Yorida, D. Turbin, S. Dedhar, C. Nelson, M. Pollak, et al. 2005. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 24: 4281-4292. (Pubitemid 40961781)
38. Basu, A., D. Datta, D. Zurakowski, and S. Pal. 2010. Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development. J. Biol. Chem. 285: 25196-25202.
39. Liu, Y. 2006. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 69: 213-217. (Pubitemid 43323069)
40. Ishimura, E., R. B. Sterzel, H. Morii, and M. Kashgarian. 1992. Extracellular matrix protein: gene expression and synthesis in cultured rat mesangial cells. Nippon Jinzo Gakkai Shi 34: 9-17.
41. Kashgarian, M., and R. B. Sterzel. 1992. The pathobiology of the mesangium. Kidney Int. 41: 524-529.
42. Matsumoto, K., S. Abiko, and H. Ariga. 2005. Transcription regulatory complex including YB-1 controls expression of mouse matrix metalloproteinase-2 gene in NIH3T3 cells. Biol. Pharm. Bull. 28: 1500-1504.
43. Dooley, S., H. M. Said, A. M. Gressner, J. Floege, A. En-Nia, and P. R. Mertens. 2006. Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J. Biol. Chem. 281: 1784-1795.
44. Uchiumi, T., A. Fotovati, T. Sasaguri, K. Shibahara, T. Shimada, T. Fukuda, T. Nakamura, H. Izumi, T. Tsuzuki, M. Kuwano, and K. Kohno. 2006. YB-1 is important for an early stage embryonic development: neural tube formation and cell proliferation. J. Biol. Chem. 281: 40440-40449.
45. Lally, C., E. Healy, and M. P. Ryan. 1999. Cyclosporine A-induced cell cycle arrest and cell death in renal epithelial cells. Kidney Int. 56: 1254-1257.
46. Jennings, P., C. Koppelstaetter, S. Aydin, T. Abberger, A. M. Wolf, G. Mayer, and W. Pfaller. 2007. Cyclosporine A induces senescence in renal tubular epithelial cells. Am. J. Physiol. Renal Physiol. 293: F831-F838.
47. Duh, J. L., H. Zhu, H. G. Shertzer, D. W. Nebert, and A. Puga. 1995. The Y-box motif mediates redox-dependent transcriptional activation in mouse cells. J. Biol. Chem. 270: 30499-30507.
48. Satriano, J. A., B. Banas, B. Luckow, P. Nelson, and D. O. Schlondorff. 1997. Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J. Am. Soc. Nephrol. 8: 596-603.
49. Coronella-Wood, J., J. Terrand, H. Sun, and Q. M. Chen. 2004. c-Fos phosphorylation induced by H2O2 prevents proteasomal degradation of c-Fos in cardiomyocytes. J. Biol. Chem. 279: 33567-33574.
50. Faul, C., M. Donnelly, S. Merscher-Gomez, Y. H. Chang, S. Franz, J. Delfgaauw, J. M. Chang, H. Y. Choi, K. N. Campbell, K. Kim, et al. 2008. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14: 931-938.
51. Skabkin, M. A., O. I. Kiselyova, K. G. Chernov, A. V. Sorokin, E. V. Dubrovin, I. V. Yaminsky, V. D. Vasiliev, and L. P. Ovchinnikov. 2004. Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res. 32: 5621-5635.
52. Evdokimova,V., P. Ruzanov,H. Imataka, B. Raught, Y. Svitkin, L. P. Ovchinnikov, and N. Sonenberg. 2001. The major mRNA-associated protein YB-1 is a potent 59 cap-dependent mRNA stabilizer. EMBO J. 20: 5491-5502. (Pubitemid 32959469)
53. Evdokimova, V., C. Tognon, T. Ng, P. Ruzanov, N. Melnyk, D. Fink, A. Sorokin, L. P. Ovchinnikov, E. Davicioni, T. J. Triche, and P. H. Sorensen. 2009. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 15: 402-415.
54. Evdokimova, V., L. P. Ovchinnikov, and P. H. Sorensen. 2006. Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle 5: 1143-1147.
55. Hayashida, T., A. C. Poncelet, S. C. Hubchak, and H. W. Schnaper. 1999. TGFbeta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 56: 1710-1720.
56. Pontrelli, P., M. Rossini, B. Infante, G. Stallone, A. Schena, A. Loverre, M. Ursi, R. Verrienti, A. Maiorano, G. Zaza, et al. 2008. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy. Transplantation 85: 125-134.